Copyright: ©Author(s) 2026.
World J Clin Pediatr. Jun 9, 2026; 15(2): 112164
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.112164
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.112164
Table 5 Levels of soluble alpha-klotho by age in control and autism spectrum disorder patient groups, mean ± SD
| Age (years) | Levels of S-KLα (pg/mL) | ||
| Control | Patients with ASD | P value | |
| 2-5 | 171.3 ± 23.5 | 129.3 ± 12.9 | 0.001 |
| 6-10 | 125.6 ± 18.1 | 89.4 ± 8.7 | 0.001 |
| 11-15 | 104.2 ± 16. 4 | 73.8 ± 8.4 | 0.001 |
| Total | 133.7 ± 32.4 | 97.5 ± 19.6 | 0.001 |
| ANOVA, P value | 0.001 | 0.001 | |
- Citation: Allwsh TA, Kucher DS. Role of soluble alpha-klotho as a novel biomarker for characterizing children with autism spectrum disorder in Kurdistan, Iraq. World J Clin Pediatr 2026; 15(2): 112164
- URL: https://www.wjgnet.com/2219-2808/full/v15/i2/112164.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v15.i2.112164